L Kristin Newby Selected Research

sibrafiban

8/2007	Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
6/2006	Statin use and sex-specific stroke outcomes in patients with vascular disease.
12/2005	Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.
9/2005	Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
10/2004	Postmenopausal hormone use in women with acute coronary syndromes.
9/2004	Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
8/2003	Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
6/2002	Prognostic significance of elevated troponin I after percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Kristin Newby Research Topics

Disease

95	Acute Coronary Syndrome 01/2022 - 06/2002
61	Myocardial Infarction 01/2022 - 02/2002
30	Hemorrhage 01/2020 - 12/2003
22	Heart Failure 01/2022 - 06/2002
22	ST Elevation Myocardial Infarction 01/2021 - 06/2004
21	Stroke (Strokes) 12/2019 - 11/2002
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2002
17	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 06/2002
13	Unstable Angina 12/2010 - 06/2003
11	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2002
10	Non-ST Elevated Myocardial Infarction 12/2021 - 05/2005
9	Inflammation (Inflammations) 10/2019 - 07/2003
8	Ischemia 03/2017 - 02/2002
7	Chest Pain (Chest Pains) 12/2021 - 04/2003
7	Diabetes Mellitus 02/2021 - 06/2002
7	Hypertension (High Blood Pressure) 10/2019 - 12/2003
7	Atrial Fibrillation 01/2018 - 06/2006
5	Necrosis 07/2012 - 04/2005
5	Thrombosis (Thrombus) 11/2008 - 08/2003
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 10/2004
4	Infarction (Infarctions) 09/2013 - 04/2009
3	Renal Insufficiency (Renal Failure) 01/2022 - 07/2005
3	Infections 01/2020 - 07/2012
3	Shock 11/2019 - 11/2012
3	Chronic Renal Insufficiency 03/2015 - 03/2008
3	Atherosclerosis 11/2008 - 07/2003
2	Idiopathic Pulmonary Fibrosis 03/2020 - 10/2019
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2015
2	Iron Deficiencies 01/2019 - 04/2010
2	Hyperlipidemias (Hyperlipidemia) 01/2016 - 01/2013
2	Heart Diseases (Heart Disease) 11/2015 - 07/2006
2	Insulin Resistance 01/2014 - 07/2013
2	Coronary Stenosis (Coronary Artery Stenosis) 07/2011 - 07/2005
2	Hypercholesterolemia 09/2009 - 04/2006

Drug/Important Bio-Agent (IBA)

29	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2002
29	TroponinIBA 01/2021 - 02/2003
23	Glycoproteins (Glycoprotein)IBA 01/2020 - 06/2002
19	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 06/2002
18	Eptifibatide (Integrilin)FDA Link 04/2014 - 06/2003
9	Clopidogrel (Plavix)FDA Link 01/2021 - 04/2006
8	MB Form Creatine KinaseIBA 09/2017 - 04/2003
8	paragonIBA 12/2010 - 02/2002
8	sibrafibanIBA 08/2007 - 06/2002
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2003
6	CreatinineIBA 01/2018 - 06/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 06/2002
5	Troponin T (Troponin T1)IBA 03/2017 - 06/2002
5	trans-crotonin (CTN)IBA 12/2015 - 03/2008
5	Warfarin (Coumadin)FDA LinkGeneric 04/2014 - 02/2010
5	Heparin (Liquaemin)FDA LinkGeneric 12/2011 - 08/2002
5	Platelet Membrane Glycoprotein IIbIBA 11/2011 - 09/2006
4	SodiumIBA 01/2022 - 01/2008
4	Hemoglobins (Hemoglobin)IBA 02/2021 - 06/2013
4	Troponin IIBA 09/2017 - 04/2003
4	Pharmaceutical PreparationsIBA 04/2016 - 07/2011
4	CytokinesIBA 02/2016 - 10/2008
4	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 03/2008
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 12/2003
3	Complement System Proteins (Complement)IBA 09/2013 - 07/2005
3	AnticoagulantsIBA 03/2013 - 11/2005
3	Ranolazine FDA Link 01/2011 - 04/2007
3	Creatine Kinase (Creatine Phosphokinase)IBA 11/2009 - 04/2003
3	Platelet Membrane GlycoproteinsIBA 02/2008 - 06/2003
3	Hormones (Hormone)IBA 09/2006 - 07/2002
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 12/2019
2	Metformin (Glucophage)FDA LinkGeneric 02/2021 - 08/2013
2	TicagrelorIBA 01/2021 - 01/2020
2	Branched-Chain Amino AcidsIBA 12/2020 - 01/2014
2	LipidsIBA 12/2020 - 01/2006
2	Prasugrel Hydrochloride FDA Link 01/2020 - 04/2017
2	CalciumIBA 10/2019 - 01/2008
2	MyoglobinIBA 09/2017 - 04/2003
2	Abciximab (ReoPro)FDA Link 01/2016 - 03/2005
2	RNA (Ribonucleic Acid)IBA 01/2015 - 11/2005
2	Biological ProductsIBA 01/2015 - 10/2013
2	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 09/2014 - 11/2012
2	p38 Mitogen-Activated Protein KinasesIBA 09/2014 - 11/2012
2	pro-brain natriuretic peptide (1-76)IBA 10/2013 - 07/2012
2	Streptokinase FDA Link 09/2013 - 12/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2013 - 12/2007
2	Triglycerides (Triacylglycerol)IBA 07/2013 - 12/2003
2	oxidized low density lipoproteinIBA 01/2013 - 09/2009
2	LDL CholesterolIBA 01/2013 - 09/2009
2	Antihypertensive Agents (Antihypertensives)IBA 01/2012 - 12/2005
2	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 11/2005
2	ORALIT (ORS)IBA 08/2007 - 09/2006
2	Estrogens (Estrogen)FDA Link 09/2006 - 07/2002

Therapy/Procedure

45	Therapeutics 01/2022 - 06/2002
30	Percutaneous Coronary Intervention 01/2022 - 07/2003
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 09/2004
7	Critical Care (Surgical Intensive Care) 11/2019 - 11/2002
7	Secondary Prevention 04/2015 - 06/2002
5	Length of Stay 12/2021 - 02/2004
4	Blood Transfusion (Blood Transfusions) 07/2013 - 10/2004
3	Erythrocyte Transfusion 04/2013 - 03/2005
2	Drug Therapy (Chemotherapy) 03/2015 - 07/2011
2	Medication Errors (Medication Error) 04/2010 - 11/2002
2	Contraindications 10/2009 - 05/2007
2	Stents 11/2008 - 08/2003